MedTrace Logo

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section

NCT07511491 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-06-23

No results posted yet for this study

Summary

This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).

Conditions

  • Ondansetron
  • Lozenge
  • Intravenous
  • Prevention
  • Shivering
  • Cesarean Section

Interventions

DRUG

Ondansetron lozenge

Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.

DRUG

Ondansetron intravenous

Patients will receive 8 mg of ondansetron IV just before the surgery.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-11
Primary Completion
2026-08-30
Completion
2026-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07511491 on ClinicalTrials.gov